+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Car T Therapies"

From
CAR T-cell Therapy: Global Strategic Business Report - Product Thumbnail Image

CAR T-cell Therapy: Global Strategic Business Report

  • Report
  • February 2024
  • 179 Pages
  • Global
From
From
From
Global and China Passenger Car T-Box Market Report, 2023 - Product Thumbnail Image

Global and China Passenger Car T-Box Market Report, 2023

  • Report
  • May 2023
  • 255 Pages
  • China, Global
From
From
CAR T - Cell Therapy - Competitive landscape, 2023 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
From
CAR-T Therapy- Pipeline Insight, 2023 - Product Thumbnail Image

CAR-T Therapy- Pipeline Insight, 2023

  • Drug Pipelines
  • November 2023
  • 550 Pages
  • Global
From
Global CAR T-Cell Therapy Market 2023-2027 - Product Thumbnail Image

Global CAR T-Cell Therapy Market 2023-2027

  • Report
  • May 2023
  • 153 Pages
  • Global
From
Global CD19 Antibody Market & Clinical Pipeline Outlook 2028 - Product Thumbnail Image

Global CD19 Antibody Market & Clinical Pipeline Outlook 2028

  • Report
  • October 2023
  • 420 Pages
  • Global
From
From
Global CD19 Antibody Market and Clinical Pipeline Outlook 2028 - Product Thumbnail Image

Global CD19 Antibody Market and Clinical Pipeline Outlook 2028

  • Report
  • October 2023
  • 420 Pages
  • Global
From
Loading Indicator

Car T therapies are a type of immunotherapy used to treat certain types of cancer. They involve the use of genetically modified T cells, which are a type of white blood cell, to recognize and attack cancer cells. The T cells are taken from the patient's blood, modified in a laboratory, and then infused back into the patient's body. This type of therapy has been used to treat certain types of leukemia and lymphoma, and is being studied for use in other types of cancer. Car T therapies are a relatively new type of oncology drug, and the market is still in its early stages. However, the potential of this type of therapy has led to a surge of interest from pharmaceutical companies, investors, and researchers. Companies are investing in research and development to improve the safety and efficacy of these therapies, as well as to expand their use to other types of cancer. Some of the companies in the Car T therapies market include Novartis, Kite Pharma, Gilead Sciences, Juno Therapeutics, and Celgene. Show Less Read more